Green & indigenous News

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities. The Kobe University achievement is the result of a rational design strategy that yields a platform for the industrial production of drug candidates.

From Biology News - Evolution, Cell theory, Gene theory, Microbiology, Biotechnology via This RSS Feed.